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Summary In recent years, fetal or autologous stem cell transplant for the treat-
ment of Parkinson’s disease (PD) has been practiced in a few medical organizations.
However, the potential complications related to the growth of allograft tissue have
not yet been well described apart from case reports. Here, we present a 42-year-old
Saudi male who suffered from early onset Parkinson’s disease. He sought medical
care in China and received autologous intrathecal stem cell transplantation. He did
not demonstrate any signiﬁcant improvement. A few months later, the patient went
back to China and underwent fetal cell transplantation into the left hemisphere and
a second stem cell transplantation intrathecally. He presented with seizures and had
a left frontal brain cyst. The cyst was drained and contained clear ﬂuid. All cultures
were negative. He had an uneventful recovery.
© 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Limited. All rights reserved.∗ Corresponding author at: Dhahran Health Center, Johns Hop-
kins Aramco Healthcare, Room A-428-2, Building 61, P.O. Box 76,
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fax: +966 13 877 3790.
E-mail addresses: jaffar.tawﬁq@jhah.com,
jaltawﬁ@yahoo.com (J.A. Al-Tawﬁq).
I
P
d
c
c
g
t
i
http://dx.doi.org/10.1016/j.jiph.2014.12.001
1876-0341/© 2015 King Saud Bin Abdulaziz University for Health Scientroduction
arkinsonism’s disease is a chronic and potentially
ebilitating neurological disease with no available
ure. Transplants of dopamine-rich fetal mesen-
ephalic allografts into the caudate, putamen and
lobus pallidus have been performed as a poten-
ial therapy for Parkinsonism’s disease [1—5]. There
s in vitro evidence that mesenteric stem cell can
nces. Published by Elsevier Limited. All rights reserved.
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Figure 1 MRI of the brain indicating the collection of a
large amount of ﬂuid in the left frontal lobe and right-
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dterile cyst formation after intrathecal stem cell tr
ifferentiate into neural cells [6] and was shown to
rotect the brain from Parkinson’s disease in ani-
al models [7,8]. However, the safety and potential
ide effects of this method has not been well doc-
mented [9]. Here we present a case of stem cell
ransplant into the brain that was complicated by
he formation of a sterile brain abscess.
ase presentation
he patient is a 42-year-old Saudi male who
uffered from early onset Parkinson’s disease
or approximately three years and has been
reated with increasing doses of dopa agonists
nd Sinemet® (carbidopa + levodopa). The patient
ad functioned reasonably well on this treatment
ith recurrent periods of akathisia interspersed
etween periods of bradykinesia. The patient went
o China and underwent autologous intrathecal
tem cell transplantation, which did not result in
igniﬁcant improvement. A few months later, the
atient returned to China where fetal cell trans-
lantation was performed in the left hemisphere
nd a second stem cell transplantation was per-
ormed intrathecally. Subsequently, his symptoms
mproved, but he continued to be treated with the
ame medications. On the day of admission, the
atient had generalized tonic clonic convulsions
ith confusion. When he reached the emergency
oom, he had recovered back to his baseline state.
hysical examination
he patient was afebrile. Vital signs were sta-
le. Cranial nerves examination was within normal
imits. He had a diffuse Parkinsonian face; other-
ise, his motor power and sensations were intact.
xtraocular movements were full, and there was
o bradykinesia. There was no tremor, but he
ad slight rigidity. He could walk with a typical
arkinsonian gait. Reﬂexes were symmetrical, and
erebellar and sensory examinations were unre-
arkable.
aboratory and radiographic data
he patient’s WBC count was 9.1 K/mm3,
emoglobin was 14.1 g/dl, hematocrit was 40%,
UN was 11mg/dl and creatinine was 0.8mg/dl.
is electrolytes were normal. His random blood
ugar was 87. Blood levels of calcium, phosphorus
nd magnesium were normal. MRI of the patient’s
rain revealed a large collection of ﬂuid in the left
rontal lobe, which measured 3.8 cm× 2.7 cm with
p
T
r
cided midline shift and a substantial mass effect on the
eft lateral and frontal lobe of the right lateral ventricle.
substantial adjacent vasogenic edema measuring
.5 cm× 5.4 cm. There was a 1.1 cm right-sided
idline shift and substantial mass effect on the
eft lateral and frontal lobe of the right lateral
entricle (Fig. 1).
ospital course and follow-up evaluation
he patient underwent an aspiration of the brain
esion, which showed clear ﬂuid. The cytology of
he ﬂuid revealed macrophages and lymphocytes.
outine cultures, fungal and mycobacterial cultures
ere all negative. The patient responded and was
ischarged home. Ten months later, a follow-up MRI
howed that most of the abnormality involving the
uperﬁcial and deep aspects of the left frontal lobe
ad resolved (Fig. 2).
iscussion
n the current report, we presented a case of
patient with Parkinson’s disease who devel-
ped a brain cyst after autologous and fetal
ntrathecal stem cell transplantation. Transplant of
opamine-rich fetal mesencephalic allografts is a
otential therapy for Parkinsonism’s disease [1—5].
he patient had referred himself to undergo this
esearch protocol. The use of fetal dopaminergic
ell transplantation may provide very long-term
384
Figure 2 Ten months later, a follow-up MRI indicating
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mesencephalic tissue into the caudate nucleus of patientsnear complete resolution of the abnormality involving the
superﬁcial and deep aspects of the left frontal lobe.
symptomatic relief in patients with Parkinson’s dis-
ease [10]. The use of autologous stem cells has been
attempted in other neurological diseases, such
as progressive supranuclear palsy (i.e., atypical
Parkinsonian disorders) [11]. Retrospective analysis
of 60 patients with Parkinson’s disease who under-
went fetal tissue transplantation showed that nine
patients experienced adverse effects and three
patients required surgical intervention [12]. In a
report of two patients who had fetal mesencephalic
tissue, the patients had good neurological recov-
ery and had discontinued pharmacotherapy 15—18
years after transplantation [13]. The pros and cons
of neurotransplantation for degenerative neuro-
logical diseases have been recently reviewed and
indicated that such studies should continue [14]. In
another review, the authors were optimistic about
the success of such of the procedures but were
cautious about the complexity of the problems, par-
ticularly the ethical and regulatory challenges [15].
A detailed description of the protocols for such
transplantations is beyond this report and has been
discussed by Lopez et al. [16].
The formation of a simple cyst following such a
transplantation could be fatal [11]. In one patient, a
simple cyst with a thin wall contained liquid identi-
cal in composition to cerebrospinal ﬂuid (CSF), and
genotyping demonstrated the presence of alleles
in the nodule DNA that were not present in lym-
phocytic DNA, indicating that the nodule containedJ.A. Al-Tawﬁq et al.
llograft tissue and thus resulted in CSF production
nd cyst formation at the transplant site [1]. The
ccumulation of ﬂuid caused herniation and death
f the patient [1]. The diagnosis in that patient was
ade 23 months after the bilateral putamen fetal
esencephalic allograft transplant [1]. In an ear-
ier report, sudden death occurred two years after
ransplant surgery and was directly attributed to
n aberrant growth of fetal tissue [17]. In contrast,
he prompt intervention and drainage of the sim-
le cyst in our case resulted in a better outcome.
hus, it is important that such patients undergo a
outine follow-up evaluation, and physicians who
re treating such patients should be aware of the
otential complications from stem cell transplanta-
ion as medical tourism becomes more adopted by
atients. These cases also highlight the importance
f careful neurological and radiographic monitoring
f patients after such procedures [1].
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